OÜ Kvatropharma
Active Registry code 12976249
OÜ Tallinn Registered 12 Jan 2016
OÜ Kvatropharma is a OÜ based in Tallinn, registry code 12976249, status: active. Main activity: Retail sale of pharmaceutical products. According to EMTA, turnover for Q3 2026 was €1 926 334 with 29 employees.
Turnover
1 926 334 €
↑ 12.0% vs Q2 2026
State taxes
12 006 €
Labour taxes
16 464 €
↑ 18.3% vs Q2 2026
Employees
29
+2 vs Q2 2026
Q3 2026 · data from the Tax and Customs Board (EMTA)
Position in the industry
- Turnover · Q3 2026 1.9 mn €above 98% of companiesindustry median 23 652 € · companies in the industry: 7 652
- Labour taxes per employee 568 €above 18% of companiesindustry median 1 201 € · companies in the industry: 4 663
- Revenue · 2025 6.2 mn €above 98% of companiesindustry median 16 974 € · companies in the industry: 13 500
- Net profit margin · 2025 -0.7 %above 33% of companiesindustry median 1.3 % · companies in the industry: 9 480
Taxes and turnover
- Company
- Industry median
Industry: Retail trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Retail trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Quarter | Turnover, € | State taxes, € | Labour taxes, € | Employees |
|---|---|---|---|---|
| Q3 2026 | 1 926 334 | 12 006 | 16 464 | 29 |
| Q2 2026 | 1 719 538 | — | 13 912 | 27 |
| Q1 2026 | 1 798 514 | — | 20 525 | 25 |
| Q4 2025 | 1 645 640 | 1 246 | 20 757 | 27 |
| Q3 2025 | 1 374 038 | 1 271 | 19 217 | 24 |
| Q2 2025 | 1 539 761 | — | 20 556 | 24 |
| Q1 2025 | 1 381 554 | 1 576 | 25 521 | 24 |
| Q4 2024 | 1 355 041 | 6 853 | 23 415 | 24 |
| Q3 2024 | 1 210 850 | 5 445 | 24 986 | 13 |
| Q2 2024 | 1 265 420 | 2 127 | 25 441 | 11 |
| Q1 2024 | 1 354 651 | 13 349 | 22 999 | 7 |
| Q4 2023 | 1 386 636 | 11 068 | 23 447 | 7 |
| Q3 2023 | 1 106 436 | 12 170 | 18 202 | 8 |
| Q2 2023 | 1 237 050 | 6 880 | 16 664 | 8 |
| Q1 2023 | 1 205 375 | 1 811 | 14 604 | 6 |
| Q4 2022 | 1 229 671 | 901 | 15 481 | 6 |
| Q3 2022 | 965 877 | — | 13 986 | 7 |
| Q2 2022 | 909 762 | 1 214 | 5 987 | 5 |
| Q1 2022 | 1 007 017 | — | 4 587 | 4 |
Labour taxes per employee per month
189 €
Turnover per employee in the quarter
66 425 €
Q3 2026 · calculated from EMTA data
Financials by year
- Company
- Industry median
Industry: Retail trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Retail trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Retail trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Retail trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Year | Revenue, € | Net profit, € | Labour costs, € | Assets, € | Equity, € | Employees |
|---|---|---|---|---|---|---|
| 2025 | 6 206 906 | -46 046 | 183 712 | 1 183 958 | -110 673 | 6 |
| 2024 | 5 140 835 | -88 151 | 240 331 | 888 076 | -64 627 | 4 |
| 2023 | 5 051 748 | 303 430 | 193 602 | 1 373 443 | 23 524 | 4 |
| 2022 | 4 208 233 | 42 611 | 120 055 | 1 017 500 | -664 871 | 3 |
| 2021 | 3 794 742 | 280 971 | 43 801 | 660 382 | -707 481 | 1 |
| 2020 | 3 538 776 | -146 396 | 411 899 | 741 825 | -988 452 | 24 |
| 2019 | 2 798 156 | -321 585 | 542 521 | 549 865 | -842 056 | 22 |
| 2018 | — | — | — | — | — | 16 |
| 2017 | — | — | — | — | — | 16 |
| 2016 | — | — | — | — | — | 11 |
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.
Financial ratios for 2025
Net profit margin
-0.7 %
Net profit / revenue
Return on assets (ROA)
-3.9 %
Net profit / assets
Equity ratio
-9.3 %
Equity / assets
Debt ratio
109.3 %
Liabilities / assets
Current ratio
0.91
Current assets / current liabilities
Revenue per employee
1 034 484 €
Revenue / average full-time employees
Labour cost per employee per month
2 552 €
Labour costs / employees / 12 months (incl. employer taxes)
Annual reports
| Year | Period | Filed | Report | Documents |
|---|---|---|---|---|
| 2025 | 1 Jan 2025 – 31 Dec 2025 | 30 Jun 2026 | Company’s own · audited | e-Äriregister |
| 2024 | 1 Jan 2024 – 31 Dec 2024 | 30 Jun 2025 | Company’s own | e-Äriregister |
| 2023 | 1 Jan 2023 – 31 Dec 2023 | 14 Jun 2024 | Company’s own · audited | e-Äriregister |
| 2022 | 1 Jan 2022 – 31 Dec 2022 | 14 Jun 2023 | Company’s own · audited | e-Äriregister |
| 2021 | 1 Jan 2021 – 31 Dec 2021 | 14 Jun 2022 | Company’s own | e-Äriregister |
| 2020 | 1 Jan 2020 – 31 Dec 2020 | 30 Jun 2021 | Company’s own · audited | e-Äriregister |
| 2019 | 1 Jan 2019 – 31 Dec 2019 | 6 Nov 2020 | Company’s own | e-Äriregister |
Board
- Malle TimbergBoard member · since 8 Jan 2021
Right of representation
Any member of the management board may represent the private limited company in all transactions.
Owners
- Malle TimbergNatural person · 5 000 €
Beneficial owners
- Malle TimbergDirect ownership · since 18 Oct 2018
Founders and other persons
- Pharmacy Invest OÜFounder · 5 000 € · 23 Dec 2015
- Grant Thornton Baltic OÜAudit firm · 30 Jul 2021
Activities (EMTAK)
- 47731Retail sale of pharmaceutical products Main
Rulings
All rulings (PDF)| Number, date | Title | Deadline | State | Document |
|---|---|---|---|---|
| Ä 50022083 / 9 21 Feb 2024 |
Amendment under Code of Civil Procedure § 595¹ (1) | In force 21 Feb 2024 |
||
| Ä 50022083 / 8 13 Dec 2023 |
Amendment entry | In force 13 Dec 2023 |
||
| Ä 50022083 / 7 3 Sep 2023 |
Amendment entry | In force 3 Sep 2023 |
||
| Ä 50022083 / M2 28 Jul 2021 |
Warning of compulsory dissolution: insufficient net assets | 29 Jan 2022 | Deficiencies eliminated 3 Jan 2024 |
|
| Ä 50022083 / 6 8 Jan 2021 |
Amendment entry | In force 8 Jan 2021 |
||
| Ä 50022083 / M1 8 Jan 2020 |
Warning of compulsory dissolution: insufficient net assets | 11 Jul 2020 | In force 8 Jan 2020 |
|
| Ä 50022083 / 5 31 Jan 2018 |
Amendment entry | In force 31 Jan 2018 |
||
| Ä 50022083 / 4 20 Jan 2018 |
Amendment entry | In force 20 Jan 2018 |
||
| Ä 50022083 / 3 8 Nov 2017 |
Amendment under Commercial Code § 525 (2) | In force 8 Nov 2017 |
||
| Ä 50022083 / 2 19 Sep 2016 |
Amendment entry | In force 19 Sep 2016 |
||
| Ä 50022083 12 Jan 2016 |
First entry | In force 12 Jan 2016 |
Sources: e-Äriregister and EMTA. Data updated 1 Nov 2026. Open at the source ↗ · Report an error in the data